Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data
Linde E. M. de Wijs(Erasmus MC), DirkJan Hijnen, Nicole S. Erler(Erasmus MC), Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), M.A. Middelkamp‐Hup(Amsterdam University Medical Centers), Tamar Nijsten(Erasmus MC), Phyllis I. Spuls, Loes M. Hollestein(Erasmus MC Cancer Institute), A.C.M. Kunkeler(Erasmus MC), Angela L. Bosma(Amsterdam University Medical Centers)
Cited by 92
Related Papers
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
|Journal of Clinical Oncology|2015|619
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
|Journal of the European Academy of Dermatology and Venereology|2022|419
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
|Journal of Investigative Dermatology|2016|377
Absence of T-regulatory cell expression and function in atopic dermatitis skin
|Journal of Allergy and Clinical Immunology|2005|272